Periodic Reporting for period 1 - INTERCEPT-T2D (Early Interception of Inflammatory-mediated Type 2 Diabetes)

Individuals with type 2 diabetes (T2D) do not use insulin efficiently and, therefore, their glucose levels rise. T2D is a heterogeneous disease, which is an obstacle to the delivery of an optimal tailored treatment. Consequently, patients’ individual trajectories of...